Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07397702
Eligibility Criteria:
Inclusion criteria:
* Men and women aged 18 to 21.
* Lead a sedentary or moderately active lifestyle (IPAQ ≤600 METs-min/week).
* Subjects diagnosed by a physician as fit for physical exercise.
* Informed consent form signed by the study subjects.
Exclusion criteria:
* Subjects with any motor disability.
* Pregnant women.
* Subjects with metabolic disorders.
* Subjects with chronic respiratory diseases such as asthma, emphysema, or cancer, obstructive pulmonary disease.
* Subjects with high blood pressure or arrhythmia.
* Failure to sign the informed consent form.
* Subjects who are in a high-performance physical training program.
* Women with irregular menstrual cycles who take contraceptive medication to regulate their menstrual cycle.
* Consumption of caffeine, alcohol, and tobacco or use of electronic cigarettes.
* Subjects with a cyclical diagnosis of anxiety and depression by a specialist.
* Frequent consumption of alcoholic beverages (more than 7 drinks per week for women and more than 14 drinks per week for men) or a history of excessive alcohol consumption.
* Subjects who consume dietary supplements (caffeine, nitric oxide precursors, beta-alanine, creatine, sodium bicarbonate, or L-carnitine).
Elimination criteria:
* Voluntary withdrawal from the study.
* Attendance at less than 80% of intervention sessions.
* Incomplete measurement schedule or insufficient sample size.
* Joint or muscle injuries caused by the training program.
* Overtraining syndrome.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
21 Years
Study:
NCT07397702
Study Brief:
Protocol Section:
NCT07397702